Assessment of the IFN-β response to four feline caliciviruses: Infection in CRFK cells

Infection, Genetics and Evolution

Volumn 34, Issue , 2015, Pages 352-360

  Tian, Jin ^a   Zhang, Xiaozhan ^a   Wu, Hongxia ^a   Liu, Chunguo ^a   Liu, Jiasen ^a   Hu, Xiaoliang ^a   Qu, Liandong ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Feline calicivirus; IFN response

Indexed keywords

BETA INTERFERON; DOUBLE STRANDED RNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; CRANDELL REES FELINE KIDNEY CELL; CYTOKINE RESPONSE; FELINE CALICIVIRUS; IN VITRO STUDY; KIDNEY CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; SENDAI VIRUS; SEQUENCE HOMOLOGY; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS SURVIVAL; ANIMAL; CALICIVIRIDAE; CALICIVIRUS INFECTION; CAT; CAT DISEASE; CELL LINE; DNA SEQUENCE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; VETERINARY; VIROLOGY;

FELIDAE; FELINE CALICIVIRUS; SENDAI VIRUS; SUS;

ANIMALS; CALICIVIRIDAE; CALICIVIRIDAE INFECTIONS; CAT DISEASES; CATS; CELL LINE; GENE EXPRESSION; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; NF-KAPPA B; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; VIRUS REPLICATION;

EID: 84937915910     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2015.06.003     Document Type: Article

References (37)

1. Alsharifi M., Lobigs M., Regner M., Lee E., Koskinen A., Mullbacher A. Type I interferons trigger systemic, partial lymphocyte activation in response to viral infection. J. Immunol. 2005, 175:4635-4640.
2. Andrejeva J., Childs K.S., Young D.F., Carlos T.S., Stock N., Goodbourn S., Randall R.E. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:17264-17269.
3. Artursson K., Gobl A., Lindersson M., Johansson M., Alm G. Molecular cloning of a gene encoding porcine interferon-beta. J. Interferon Res. 1992, 12:153-160.
4. Ballin A.C., Schulz B., Helps C., Sauter-Louis C., Mueller R.S., Hartmann K. Limited efficacy of topical recombinant feline interferon-omega for treatment of cats with acute upper respiratory viral disease. Vet. J. 2014, 202:466-470.
5. Bittle J.L., Rubic W.J. Immunization against feline calicivirus infection. Am. J. Vet. Res. 1976, 37:275-278.
6. Bolin V.S. The cultivation of panleucopenia virus in tissue culture. Virology 1957, 4:389-390.
7. Cave T.A., Thompson H., Reid S.W., Hodgson D.R., Addie D.D. Kitten mortality in the United Kingdom: a retrospective analysis of 274 histopathological examinations (1986 to 2000). Vet. Rec. 2002, 151:497-501.
8. Coyne K.P., Gaskell R.M., Dawson S., Porter C.J., Radford A.D. Evolutionary mechanisms of persistence and diversification of a calicivirus within endemically infected natural host populations. J. Virol. 2007, 81:1961-1971.
9. de Los Santos T., de Avila Botton S., Weiblen R., Grubman M.J. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J. Virol. 2006, 80:1906-1914.
10. Didcock L., Young D.F., Goodbourn S., Randall R.E. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J. Virol. 1999, 73:9928-9933.
11. Fensterl V., Grotheer D., Berk I., Schlemminger S., Vallbracht A., Dotzauer A. Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon. J. Virol. 2005, 79:10968-10977.
12. Fulton R.W., Burge L.J. Susceptibility of feline herpesvirus 1 and a feline calicivirus to feline interferon and recombinant human leukocyte interferons. Antimicrob. Agents Chemother. 1985, 28:698-699.
13. Gerlach N., Schimmer S., Weiss S., Kalinke U., Dittmer U. Effects of type I interferons on Friend retrovirus infection. J. Virol. 2006, 80:3438-3444.
14. Gil S., Leal R.O., McGahie D., Sepulveda N., Duarte A., Niza M.M., Tavares L. Oral recombinant feline interferon-omega as an alternative immune modulation therapy in FIV positive cats: clinical and laboratory evaluation. Res. Vet. Sci. 2014, 96:79-85.
15. Haller O., Kochs G., Weber F. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 2006, 344:119-130.
16. Liu C., Liu Y., Liu D., Guo D., Liu M., Li Y., Qu L. Complete genome sequence of feline calicivirus strain HRB-SS from a cat in Heilongjiang province, northeastern China. Genome Announc. 2014, 2.
17. Oka T., Takagi H., Saif L.J., Wang Q. Complete genome sequence of the feline calicivirus 2280 strain from the American tissue culture collection. Genome Announc. 2013, 1.
18. Orr C.M., Gaskell C.J., Gaskell R.M. Interaction of an intranasal combined feline viral rhinotracheitis, feline calicivirus vaccine and the FVR carrier state. Vet. Rec. 1980, 106:164-166.
19. Ossiboff R.J., Parker J.S. Identification of regions and residues in feline junctional adhesion molecule required for feline calicivirus binding and infection. J. Virol. 2007, 81:13608-13621.
20. Ossiboff R.J., Sheh A., Shotton J., Pesavento P.A., Parker J.S. Feline caliciviruses (FCVs) isolated from cats with virulent systemic disease possess in vitro phenotypes distinct from those of other FCV isolates. J. Gen. Virol. 2007, 88:506-517.
21. Prikhodko V.G., Sandoval-Jaime C., Abente E.J., Bok K., Parra G.I., Rogozin I.B., Ostlund E.N., Green K.Y., Sosnovtsev S.V. Genetic characterization of feline calicivirus strains associated with varying disease manifestations during an outbreak season in Missouri (1995-1996). Virus Genes 2014, 48:96-110.
22. Radford A.D., Addie D., Belak S., Boucraut-Baralon C., Egberink H., Frymus T., Gruffydd-Jones T., Hartmann K., Hosie M.J., Lloret A., Lutz H., Marsilio F., Pennisi M.G., Thiry E., Truyen U., Horzinek M.C. Feline calicivirus infection. ABCD guidelines on prevention and management. J. Feline Med. Surg. 2009, 11:556-564.
23. Reed L.J., Müench H. A simple method of estimating fifty percent endpoints. Am. J. Epidemiol. 1938, 27:493-497.
24. Rodriguez-Calvo T., Rojas J.M., Martin V., Sevilla N. Type I interferon limits the capacity of bluetongue virus to infect hematopoietic precursors and dendritic cells in vitro and in vivo. J. Virol. 2014, 88:859-867.
25. Sosnovtsev S.V., Garfield M., Green K.Y. Processing map and essential cleavage sites of the nonstructural polyprotein encoded by ORF1 of the feline calicivirus genome. J. Virol. 2002, 76:7060-7072.
26. Thiry E., Addie D., Belak S., Boucraut-Baralon C., Egberink H., Frymus T., Gruffydd-Jones T., Hartmann K., Hosie M.J., Lloret A., Lutz H., Marsilio F., Pennisi M.G., Radford A.D., Truyen U., Horzinek M.C. Feline herpesvirus infection. ABCD guidelines on prevention and management. J. Feline Med. Surg. 2009, 11:547-555.
27. Thumfart J.O., Meyers G. Feline calicivirus: recovery of wild-type and recombinant viruses after transfection of cRNA or cDNA constructs. J. Virol. 2002, 76:6398-6407.
28. Wang X., Li M., Zheng H., Muster T., Palese P., Beg A.A., Garcia-Sastre A. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J. Virol. 2000, 74:11566-11573.
29. Wang D., Fang L., Luo R., Ye R., Fang Y., Xie L., Chen H., Xiao S. Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced type I interferon transcription by decreasing interferon regulatory factor 3/7 in protein levels. Biochem. Biophys. Res. Commun. 2010, 399:72-78.
30. Wang D., Fang L., Bi J., Chen Q., Cao L., Luo R., Chen H., Xiao S. Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced RANTES transcription in PK-15 cells. Virus Genes 2011, 42:388-393.
31. Wathelet M.G., Lin C.H., Parekh B.S., Ronco L.V., Howley P.M., Maniatis T. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol. Cell 1998, 1:507-518.
32. Weiss R.C., Toivio-Kinnucan M. Inhibition of feline infectious peritonitis virus replication by recombinant human leukocyte (alpha) interferon and feline fibroblastic (beta) interferon. Am. J. Vet. Res. 1988, 49:1329-1335.
33. Widdowson M.A., Monroe S.S., Glass R.I. Are noroviruses emerging?. Emerg. Infect. Dis. 2005, 11:735-737.
34. Wolferstatter M., Schweneker M., Spath M., Lukassen S., Klingenberg M., Brinkmann K., Wielert U., Lauterbach H., Hochrein H., Chaplin P., Suter M., Hausmann J. Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses. J. Virol. 2014, 88:14396-14411.
35. Wong W.T., Kelman M., Ward M.P. Surveillance of upper respiratory tract disease in owned cats in Australia, 2009-2012. Prevent. Vet. Med. 2013, 112:150-155.
36. Yie J., Senger K., Thanos D. Mechanism by which the IFN-beta enhanceosome activates transcription. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:13108-13113.
37. Yokota S., Yokosawa N., Okabayashi T., Suzutani T., Miura S., Jimbow K., Fujii N. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway. J. Virol. 2004, 78:6282-6286.